Recently Diagnosed? What To Expect, with Health Monitor Health Monitor

Yale oncologist Maryam Lustberg, MD, describes metastatic breast cancer, with a special focus on HR+/HER2-, which accounts for 70% of all breast cancers.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dana-Farber Cancer Institute oncologist Sara Tolaney, MD, MPH, explains treatment options for HR+/HER2- metastatic breast cancer, including aromatase inhibitors and CDK4/6 inhibitors.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Lustberg returns to explain how patients and oncologists work together to decide on a course of action, including what to expect from treatment and ongoing monitoring and why you have every reason to be optimistic.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jennifer Klemp, PhD, MPH, an expert in breast cancer survivorship, discusses the lifestyle adjustments that can set you up for success throughout your journey.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Kristy Case, MSW, LCSW, OSW-C, discusses coping techniques—from grounding exercises to gratitude practices—that help patients stay centered.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.